skip to main content
Idioma:
Mostrar Somente
Refinado por: assunto: Oncology remover assunto: Pharmacology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Repetitive Magnetic Stimulation for the Management of Peripheral Neuropathic Pain: A Systematic Review
Repetitive Magnetic Stimulation for the Management of Peripheral Neuropathic Pain: A Systematic Review
Material Type:
Artigo 		Adicionar ao Meu Espaço

Repetitive Magnetic Stimulation for the Management of Peripheral Neuropathic Pain: A Systematic Review

Aamir, Abdullah ; Girach, Ayesha ; Sarrigiannis, Ptolemaios Georgios ; Hadjivassiliou, Marios ; Paladini, Antonela ; Varrassi, Giustino ; Zis, Panagiotis

Advances in therapy, 2020-03, Vol.37 (3), p.998-1012 [Periódico revisado por pares]

Cheshire: Springer Healthcare

Texto completo disponível

Citações Citado por
2
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors
A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors

Abdul Razak, Albiruni R. ; Miller, Wilson H. ; Uy, Geoffrey L. ; Blotner, Steven ; Young, Anne-Marie ; Higgins, Brian ; Chen, Lin-Chi ; Gore, Lia

Investigational new drugs, 2020-08, Vol.38 (4), p.1156-1165 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
3
Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer
Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Cytotoxic and radiosensitising effects of a novel thioredoxin reductase inhibitor in breast cancer

Abdullah, Nurul A ; Inman, Martyn ; Moody, Christopher J. ; Storr, Sarah J ; Martin, Stewart G

Investigational new drugs, 2021-10, Vol.39 (5), p.1232-1241 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
4
Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
Material Type:
Artigo 		Adicionar ao Meu Espaço

Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels

Abinusawa, Adeyinka ; Tenjarla, Srini

Advances in therapy, 2015-05, Vol.32 (5), p.477-484 [Periódico revisado por pares]

Cheshire: Springer Healthcare

Texto completo disponível

Citações Citado por
5
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment
Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pharmacokinetics and safety of vismodegib in patients with advanced solid malignancies and hepatic impairment

Abou-Alfa, Ghassan K. ; Lewis, Lionel D. ; LoRusso, Patricia ; Maitland, Michael ; Chandra, Priya ; Cheeti, Sravanthi ; Colburn, Dawn ; Williams, Sarah ; Simmons, Brian ; Graham, Richard A.

Cancer chemotherapy and pharmacology, 2017-07, Vol.80 (1), p.29-36 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
6
A note on improved statistical approaches to account for pseudoprogression
A note on improved statistical approaches to account for pseudoprogression
Material Type:
Artigo 		Adicionar ao Meu Espaço

A note on improved statistical approaches to account for pseudoprogression

Abrouk, Nacer ; Oronsky, Bryan ; Caroen, Scott ; Ning, Shoucheng ; Knox, Susan ; Peehl, Donna

Cancer chemotherapy and pharmacology, 2018-03, Vol.81 (3), p.621-626 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
7
Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeting Anticancer Drugs to Tumor Vasculature Using Cationic Liposomes

Abu Lila, Amr S ; Ishida, Tatsuhiro ; Kiwada, Hiroshi

Pharmaceutical research, 2010-07, Vol.27 (7), p.1171-1183 [Periódico revisado por pares]

Boston: Boston : Springer US

Texto completo disponível

Citações Citado por
8
Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells
Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells
Material Type:
Artigo 		Adicionar ao Meu Espaço

Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells

Aggarwal, Sadhna ; John, Sarah ; Sapra, Leena ; Sharma, Suresh C. ; Das, Satya N.

Cancer chemotherapy and pharmacology, 2019-03, Vol.83 (3), p.451-461 [Periódico revisado por pares]

Berlin/Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
9
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors
A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients with solid tumors

Aghajanian, Carol ; Bell-McGuinn, Katherine M. ; Burris, Howard A. ; Siu, Lillian L. ; Stayner, Lee-Ann ; Wheler, Jennifer J. ; Hong, David S. ; Kurkjian, Carla ; Pant, Shubham ; Santiago-Walker, Ademi ; Gauvin, Jennifer L. ; Antal, Joyce M. ; Opalinska, Joanna B. ; Morris, Shannon R. ; Infante, Jeffrey R.

Investigational new drugs, 2018-12, Vol.36 (6), p.1016-1025 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
10
Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life
Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life
Material Type:
Artigo 		Adicionar ao Meu Espaço

Transarterial Radioembolization Versus Atezolizumab–Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life

Agirrezabal, Ion ; Brennan, Victoria K. ; Colaone, Fabien ; Shergill, Suki ; Pereira, Helena ; Chatellier, Gilles ; Vilgrain, Valérie

Advances in therapy, 2022-05, Vol.39 (5), p.2035-2051 [Periódico revisado por pares]

Cheshire: Springer Healthcare

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (1.414)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (1.414)
  2. Livros  (71)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1990  (18)
  2. 1990Até1997  (41)
  3. 1998Até2005  (23)
  4. 2006Até2014  (646)
  5. Após 2014  (777)
  6. Mais opções open sub menu

Idioma 

  1. Japonês  (393)
  2. Alemão  (3)
  3. Russo  (1)
  4. Holandês  (1)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.